StonvexLoading…
StonvexStonvexStonvexCore line items from DQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $665.41M | $1.03B | $2.31B | $4.61B |
Operating Income | $-270.24M | $-564.09M | $783.43M | $3.04B |
Net Income | $-170.51M | $-345.21M | $429.55M | $1.82B |
EPS (Diluted) | $-0.51 | $-1.04 | $1.15 | $4.67 |
Total Assets | $6.45B | $6.42B | $7.43B | $7.59B |
Total Liabilities | $533.01M | $560.38M | $978.58M | $989.49M |
Cash & Equivalents | $856.05M | $1.01B | $3.04B | $3.50B |
Free Cash Flow OCF − CapEx | $-123.34M | $-794.25M | $505.30M | $1.26B |
Shares Outstanding | 338.33M | 333.76M | 328.51M | 391.02M |